ArticleFrontiers in chemistry2023

Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma.

Eman M Radwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.